Green Valley Drugs Recalls Procaine Hydrochloride Injection Due to Sterility Concerns
FVS Holdings, Inc. dba. Green Valley Drugs is recalling 70 vials of Procaine Hydrochloride Injection nationwide due to a lack of assurance of sterility in its compounding and quality control processes.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the rubric, an FDA Class II recall involving a significant risk of harm, such as a lack of sterility assurance in injectable drugs, corresponds to a severity score of 4 (Severe).
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling 70 vials of Procaine Hydrochloride Injection, available in various strengths and presentations, including Procaine 2% 30 mL PF, Procaine HCl 2% 10 mL, Procaine HCl 20 mg/mL 30 mL, Procaine HCl 1% 50 mL MDV, and Procaine HCl 1% PF 5 mL and 30 mL. The affected product is identified by Lot # 20130405-B with an expiration date of 7/5/2013. The recall is being conducted nationwide.
The recall is due to a lack of assurance of sterility for all sterile products compounded, repackaged, and distributed by the pharmacy. This issue stems from concerns associated with the company's quality control processes. The FDA has classified this recall as Class II.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions on how to return or dispose of the medication.
The recalled product
- Product
- Procaine Hydrochloride Injection, all strengths and all presentations, including a) Procaine 2% 30 mL PF, b) Procaine HCl 2% 10 mL, c) Procaine HCl 20 mg/mL 30 mL, d) Procaine HCl 1% 50 mL MDV, e) Procaine HCl 1% PF 5 mL, 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa…
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable
- Hazard
- Affected units
- 70
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: a) 20130405-B
- Exp 7/5/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- HighWestern Drug Recalls Procaine HCl Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SeverePromise Pharmacy Recalls Procaine HCl Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereDowning Labs Recalls Procaine Injectables Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereKey Pharmacy Recalls Procaine HCL Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighProcaine HCL Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-07-20
- SevereBeacon Hill Medical Pharmacy Recalls Procaine Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-09-18